RECTAL CANCERS
Clinical trials for RECTAL CANCERS explained in plain language.
Never miss a new study
Get alerted when new RECTAL CANCERS trials appear
Sign up with your email to follow new studies for RECTAL CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple threat: immunotherapy, chemo, and radiation take on rectal cancer
Disease control Not yet recruitingThis phase 2 trial is testing whether adding an immunotherapy drug (adebrelimab) to a chemotherapy combo (NALIRIFOX) and radiation can improve outcomes for people with a certain type of locally advanced rectal cancer (pMMR/MSS). About 84 participants will be randomly assigned to …
Matched conditions: RECTAL CANCERS
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC
-
Shorter radiation with Real-Time adjustments could reduce side effects
Disease control Not yet recruitingThis study tests whether daily adaptive radiotherapy (ART) can safely deliver shorter, more intense radiation treatments for prostate, endometrial, cervical, and rectal cancers. About 264 participants will be randomly assigned to standard radiation or ART, which uses daily imagin…
Matched conditions: RECTAL CANCERS
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC